Upper urinary tract transitional cell carcinoma: Location is not correlated with prognosis

BJU International

Volumn 109, Issue 7, 2012, Pages 1037-1042

  Milojevic, Bogomir ^a   Djokic, Milan ^a   Sipetic Grujicic, Sandra ^b   Milenkovic Petronic, Dragica ^a   Vuksanovic, Aleksandar ^a   Bumbasirevic, Uros ^a   Vukovic, Ivan ^a   Dragicevic, Dejan ^a   Tulic, Cane ^a  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

recurrence; renal pelvis; survival; transitional cell carcinoma; ureter

Indexed keywords

AGED; ARTICLE; BALKAN ENDEMIC NEPHROPATHY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY PELVIS TUMOR; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHROURETERECTOMY; PATIENT CODING; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TRANSITIONAL CELL CARCINOMA; TUMOR LOCALIZATION; URETER TUMOR; URINARY TRACT CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; PROGNOSIS; SURVIVAL RATE; URETER; URETERAL NEOPLASMS;

EID: 84858450920     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10461.x     Document Type: Article

References (22)

1. Jamal A, Siegel R, Ward E, et al,. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-30
2. Hall MC, Womack S, Sagalowsky AI, et al,. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology 1998; 52: 594-601 (Pubitemid 28440164)
3. Dragicevic D, Djokic M, Pekmezovic T, et al,. Survival of patients with transitional cell carcinoma of the ureter and pelvis in Balkan endemic nephropathy and non-endemic areas of Serbia. BJU Int 2007; 99: 1357-62 (Pubitemid 47164802)
4. Roscigno M, Cozzarini C, Bertini R, et al,. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol 2008; 53: 794-802
5. Raman JD, Ng CK, Scherr DS, et al,. Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy. Eur Urol 2010; 57: 1072-9
6. Kikuchi E, Margulis V, Karakiewicz PI, et al,. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 2009; 27: 612-8
7. Favaretto RL, Shariat SF, Chade DC, et al,. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol 2010; 58: 574-80
8. Park S, Hong B, Kim CS, et al,. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 2004; 171: 621-5 (Pubitemid 38090443)
9. Isbarn H, Jeldres C, Shariat SF, et al,. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. J Urol 2009; 182: 2177-81
10. Fleming ID, Cooper JS, Henson DE, et al,. Genitourinary site. In, Touhey R, ed., AJCC Cancer Staging Manual, 5th edn. Philadelphia: Lippincott-Raven, 1997: 231-46
11. Epstein JI, Amin MB, Reuter VR, et al,. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998; 22: 1435-48 (Pubitemid 28550639)
12. Djokic M, Hadzi-Djokic J, Nikolic J, et al,. Comparison of upper urinary tract tumors in the region of Balkan nephropathy with those of other regions of Yugoslavia. Prog Urol 1999; 9: 61-8
13. Markovic N, Ignjatovic I, Cukuranovic R, et al,. Decreasing incidence of urothelial cancer in a Balkan endemic nephropathy region in Serbia. A surgery based study from 1969-1998. Pathol Biol (Paris) 2005; 53: 26-9 (Pubitemid 40037251)
14. Van der Poel HG, Antonini N, Van Tinteren H, et al,. Upper urinary tract cancer: location is correlated with prognosis. Eur Urol 2005; 48: 438
15. Park J, Ha SH, Min GE, et al,. The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival. J Urol 2009; 182: 894-9
16. Margulis V, Shariat SF, Matin SF, et al,. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 2009; 115: 1224-33
17. Akdogan B, Dogan HS, Eskicorapci SY, et al,. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol 2006; 176: 48-52 (Pubitemid 43815384)
18. Cukuranovic R, Ignjatovic M, Stefanovic V,. Urinary tract tumors and Balkan nephropathy in South Morava river basin. Kidney Int 1991; 40 (Suppl. 34): 80-4
19. Vukelic M, Sostaric B, Belicza M,. Pathomorphology of Balkan endemic nephropathy. Food Chem Toxicol 1992; 30: 193-200
20. Karmaus W, Dimitrov P, Simeonov V, et al,. Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal study. BMC Nephrol 2009; 10: 10
21. Grollman AP, JelakoviÄ B,. Role of environmental toxins in endemic (Balkan) nephropathy. J Am Soc Nephrol 2007; 18: 2817-23 (Pubitemid 350064082)
22. Milojevic B, Djokic M, Sipetic-Grujicic S, et al,. Bladder cancer after managing upper urinary tract transitional cell carcinoma: risk factors and survival. Int Urol Nephrol 2011; doi: 10.1007/s11255-011-9902-4